skip to the content

Clinical Trials

Thrombosis - Antibody Study

Bridging Inflammation and Thrombosis:  Exploring the Effects of Antiphospholipid Antibodies and Tumor Necrosis Factor of Thrombosis

Protocol ID

04-029

Protocol Description

The goal of this research is to better understand the role of antiphospholipid antibodies in blood clotting (thrombosis). Patients with antiphospholipid antibody syndrome make antibodies that have been associated with an increased risk of thrombosis (stroke: blood clot in the brain; phlebitis: blood clot in the veins of the arms or legs). The way these antibodies cause thrombosis is unknown. The researchers performing this study will analyze blood samples taken from patients with antiphospholipid antibodies in order to examine how antiphospholipid antibodies affect blood clot formation.

Eligibility Criteria

Patients with antiphospholipid antibody syndrome

Primary Investigator(s)

  • Richard Furie, MD

Contact Information

Laura Donohue, CCRC
(516) 708-2558
ldonohue@nshs.edu

Last Update

March 26, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Blood Disorders:
top
top